BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Daina Graybosch does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 BOLTBolt Biotherapeutics | Buy | $4.00 | May 2023 | −42.3% | Miss |
 IPHAInnate Pharma | Buy | $9.00 | Nov 2022 | +11.1% | Miss |
| IPHAInnate Pharma | Buy | $10.00 | Aug 2022 | +0.9% | Miss |
| IPHAInnate Pharma | Buy | $11.00 | May 2022 | +2.6% | Miss |
 MOLNMolecular Partners AG ADR | Buy | $29.00 | Apr 2022 | −23.4% | Miss |
| MOLNMolecular Partners AG ADR | Buy | $42.00 | Jan 2022 | −77.1% | Miss |
| BOLTBolt Biotherapeutics | Buy | $33.00 | Nov 2021 | −90.2% | Miss |
| IPHAInnate Pharma | Buy | $9.00 | Sep 2021 | −65.6% | Miss |
| MOLNMolecular Partners AG ADR | Buy | $35.00 | Aug 2021 | −64.9% | Miss |
| BOLTBolt Biotherapeutics | Buy | $35.00 | Aug 2021 | −82.6% | Miss |
| BOLTBolt Biotherapeutics | Buy | $33.00 | May 2021 | −98.9% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.